Industry Focus
Amgen Inc: Why You Shouldn't Count Chickens Before They Hatch
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:14:10
- Mas informaciones
Informações:
Sinopsis
Amgen has shelved its once-promising psoriasis drug. Motley Fool's Michael Douglass and Todd Campbell help investors understand the impact.
